US drugmaker Eli Lilly’s combination of two synthetic antibodies reduced hospitalizations and deaths in high-risk patients recently diagnosed with COVID-19 by 87 percent in trials, the […]
A recent Loyola Medicine study found that reducing the standard dose of IV-administered ketamine in half is as effective as the larger, standard dose in reducing […]
Healthcare personnel who were infected with COVID-19 had stronger risk factors outside the workplace than in their hospital or healthcare setting. That is the finding of […]
While neurological complications of COVID-19 in children are rare, in contrast to adults, an international expert review of positive neuroimaging findings in children with acute and […]